Table 4 Summary of univariate and multivariate Cox regression analyses of relapse-free survival duration.
From: Low CYP24A1 mRNA expression and its role in prognosis of breast cancer
Parameters | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
Age | 1.45 | 0.97–2.16 | 0.072 |  |  |  |
Histological type | 0.86 | 0.65–1.14 | 0.29 |  |  |  |
Molecular subtype | 0.99 | 0.82–1.2 | 0.945 |  |  |  |
ER | 0.78 | 0.63–0.97 | 0.026 | 0.74 | 0.54–1.03 | 0.075 |
PR | 0.78 | 0.64–0.96 | 0.019 | 0.87 | 0.64–1.17 | 0.345 |
HER2 | 0.93 | 0.7–1.22 | 0.596 |  |  |  |
Menopause status | 0.95 | 0.74–1.22 | 0.713 |  |  |  |
Stage | 1.71 | 1.4–2.08 | 0.000 | 1.64 | 1.31–2.05 | 0.000 |
Lymph node status | 0.86 | 0.7–1.06 | 0.159 |  |  |  |
Margin status | 1.59 | 1.23–2.06 | 0.000 | 1.43 | 1.09–1.88 | 0.009 |
CYP24A1 | 2.22 | 1.48–3.33 | 0.000 | 2.61 | 1.68–4.05 | 0.000 |
